Isochem showing Vitamin E TPGS and custom manufacturing at key events

Vert-Le-Petit, France: – Intermediates and active ingredients specialist CMO Isochem will be present at key events in Germany and the USA during March showcasing its latest product, Vitamin E TPGS excipient, and supporting its custom manufacturing offer for pharmaceutical companies worldwide.

Teams form Isochem will be present at next month’s prestige DCAT Week industry show in New York City, immediately followed by the German Drug Delivery & formulation (DDF) Summit in Berlin.

At the DDF Summit, Isochem will be presenting a highly innovative product, Vitamin E TPGS that provides an attractive excipient for innovative drug delivery. At DCAT Week, the company’s primary focus will be on its bespoke pharmaceutical cGMP production capabilities summarized in its new strapline ‘Isochem: Your Partner For Smart Custom Manufacturing’.

TPGS solubility improvement

Tocopheryl polyethylene glycol succinate (TPGS) is natural Vitamin E derivative, non-ionic surfactant that provides an attractive tool for solubility improvement, for stabilizing micro emulsions and for building nanoparticles in drug formulation.

“Isochem has become a key producer and supplier of Vitamin E TPGS, offering top level service by delivering cGMP product from research quantities to multi-tons for commercial phase,” explained Vice President Sales & Business Development, Amélie Arbore, who will once again lead the company’s DCAT team in New York.

Custom synthesis

“We believe most of the people we meet in New York will be primarily interested in our custom manufacturing capabilities that now include full cGMP production facilities, route selection, process and analytical development and process optimization from laboratory scale to full production, as well as delivery of safe implementation of hazardous reactions and versatile chemistry,” said Ms. Arbore.

Isochem will also be presenting newly developed offers on development projects, made possible by recent expansion of its teams and capabilities in R&D and project management.

The past 24 months have seen Isochem enjoy increasing productivity gained from its strategy of refocusing on its pharma portfolio, in particular custom synthesis, catalog products, generic APIs and excipients.

About Isochem

Isochem S.A.S. is a custom manufacturing organization with a century-old heritage in fine chemistry and a 40-year track record in providing high quality fine chemicals, API building blocks and high value molecules, as well as mastering complex processes. The company can manufacture products and provide services to the most recent and stringent pharmaceutical regulatory standards.

Isochem serves a broad range of customers in many application fields, from leading global companies to virtual and emerging organizations, offering services in three pharma-related fields: custom synthesis, high technology manufacturing in multi-step chemical synthesis including the safe implementation of hazardous reactions, and direct supply of more than 2,300 specific compounds and products, including phosgene derivatives, regulated and non-regulated intermediates and active ingredients.

Isochem can also provide attractive synthetic tools such as activated aminoacids building blocks (N-CarboxyAnhydride NCA) used in peptide chemistry. It is also expert in process optimization from pre-clinical development to full-scale production.

Isochem is now an international company with some 350 employees worldwide. The Head office is located near Paris, in Vert-Le-Petit, France, on one of Isochem’s five manufacturing sites. The company is a wholly owned subsidiary of Munich-based Aurelius AG.

About DCAT Week

The Drug, Chemical & Associated Technologies Association (DCAT), founded in 1890, has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.

DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.

Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, are considered one of the pharma industry’s premier events.

DCAT Week 2017 will take place over four days from March 20 to March 23. Renovation at Waldorf Astoria has meant that the event’s traditional headquarters is unavailable this year, with activities shared between seven other downtown hotels including the Lotte New York Palace, Omni Berkshire Place, 48LEX, Benjamin and InterContinental Barclay, with the 91st DCAT Annual Dinner held in the Grand Ballroom of the New York Hilton on Thursday, March 23.

The event is organized by DCAT with more information at: https://www.dcat.org/

About DDF ‘17

The Drug Delivery & Formulation (DDF) Summit brings together delegates from pharmaceutical, technology and academic fields to discuss latest trends in pharma.

DDF ‘17 will focusing on new technologies, concepts and case studies in areas that include oral delivery of biologics, injectability of highly concentrated protein formulations, control of amorphous solid dispersions, nanoparticle technology, pediatric medicine and the latest microneedle and transdermal delivery systems.

DDF ’17 is a three-day event opening March 27 at the Maritim proArte Hotel, in Berlin’s Friedrichstrasse. Keynote speakers will include Ex-FDA Director of Product Research, Dr Mansoor Khan.

The event is organized by Mark Allen Group with more information at: http://www.ddfevent.com